Botfet / Company detail

KRYS

universe

Krystal Biotech, Inc.

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic13.1%

Gross Margin92.6%

Revenue Cagr177.0%

Fcf Conversion92.2%

Fcf Yield2.0%

Interest Coverage0.0x

Market Cap B$9.3B

Pe37.7

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener